OM1, a health technology company focused on real-world outcomes for chronic conditions, today announced an $85 million financing led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital, with participation from existing investors, including General Catalyst (GC), Polaris Partners, Scale Venture Partners, 7wireVentures, and Glikvest.
Jan 1, 2019 | 7wireventures.comOM1, a healthcare data and analytics company, raised $85 million in a Series D financing round co-led by Oakland, California-based Kaiser Permanente.
Jan 1, 2021 | medcitynews.comOM1 announced the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci.
Jan 1, 2022 | appliedclinicaltrialsonline.com